Core Insights - Sisram Medical Ltd, through its subsidiary Alma, showcased advancements in Intelligent Aesthetics at the IMCAS World Congress, emphasizing a technology-driven approach to aesthetic treatments [1] - The company presented new clinical data and case studies that reinforce its leadership in energy-based aesthetic solutions, particularly in scar management, rejuvenation, and tattoo removal [1] Group 1: Company Developments - Alma highlighted its innovative multi-technology laser platforms for various applications, including advanced laser-based rejuvenation and complex tattoo removal [1] - The Alma Hybrid platform was featured for its effectiveness in managing keloid scars in conjunction with surgery and steroid delivery [1] - The company’s advanced skin analysis platform, Alma IQ, supports personalized assessments and treatment planning from the initial patient interaction [1] Group 2: Industry Impact - The IMCAS World Congress serves as a significant platform for discussing the future of medical aesthetics, with Sisram's participation underscoring its commitment to evidence-based practices and technological innovation [1] - Discussions at the congress included the role of intelligent technologies and clinical insights in shaping the future landscape of medical aesthetics, attended by industry leaders [1]